ArticleJHEP reports : innovation in hepatology2025

Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis.

Yirui Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.